Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of fluorouracil given as a continuous
infusion in treating patients with recurrent or metastatic bladder cancer.